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Available online 14 April 2016Group Person-Based Cognitive Therapy (PBCT) integrates cognitive therapy and mindfulness to target distinct
sources of distress in psychosis. The present study presents data from the ﬁrst randomised controlled trial inves-
tigating groupPBCT inpeople distressed byhearing voices. One-hundred and eight participantswere randomised
to receive either group PBCT and Treatment As Usual (TAU) or TAU only.While therewas no signiﬁcant effect on
the primary outcome, a measure of general psychological distress, results showed signiﬁcant between-group
post-intervention beneﬁts in voice-related distress, perceived controllability of voices and recovery. Participants
in the PBCT group reported signiﬁcantly lower post-treatment levels of depression, with this effectmaintained at
six-month follow-up. Findings suggest PBCT delivered over 12 weeks effectively impacts key dimensions of the
voice hearing experience, supports meaningful behaviour change, and has lasting effects on mood.
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Randomised Controlled Trial1. Introduction
Individual Cognitive Behaviour Therapy for Psychosis (CBTp) is rec-
ommended in the US and UK for the treatment of schizophrenia and
schizoaffective disorder (e.g. National Collaborating Centre for Mental
Health, 2014) – though in the UK, where CBTp is longer established, ac-
cess to individual CBTp remains poor (The Schizophrenia Commission,
2012) and group CBTp lacks sufﬁciently robust evidence to be recom-
mended by the National Institute for Clinical Excellence.
Evidence is building for the beneﬁts of groupmindfulness-based in-
terventions (MBIs) for psychosis (Chadwick et al., 2005; Khoury et al.,
2013; Lopez-Navarro et al., 2015), including for distressing voices
(Chadwick et al., 2009). Mindfulness is a state of non-judgemental and
accepting awareness of present-moment experiences (such as
thoughts, voices and bodily sensations). Qualitative research reveals
how learning to respond mindfully to difﬁcult psychotic symptoms
can reduce distress and facilitate increased acceptance of both psychosislogy, Institute of Psychiatry,
n SE5 8AF, UK.
).
. This is an open access article underand the self (Abba et al., 2008). Person-Based Cognitive Therapy (PBCT;
Chadwick, 2006) integrates CBTp and mindfulness and was developed
speciﬁcally for people with distressing psychosis (though has since
been found to signiﬁcantly beneﬁt people with chronic depression:
Strauss et al., 2012). It has long been argued that CBTp aims at reducing
distress and disturbance, not psychotic symptoms (e.g. Chadwick et al.,
1996), and PBCT explicitly targets three distinct sources of distress/dis-
turbance: persecutory delusions and beliefs about voices (‘symptomatic
meaning’); self-defeating reactions to psychotic symptoms (e.g. experi-
ential avoidance, ﬁghting with voices, paranoid rumination); and core
beliefs (schemata) that deﬁne the self as negative and ﬁxed. Therapy
combines guided discovery, behavioural experiments, a focus on posi-
tive behaviour change, mindfulness practice, and a strong experiential
focus.
Auditory hallucinations (voices) are often experienced as highly
distressing and disturbing (Birchwood and Chadwick, 1997). Two
randomised controlled trials of group CBTp speciﬁcally for people with
distressing voices have been published. Wykes et al. (2005) reported
improvement in social functioning but no effect upon the severity of
voices. Penn et al. (2009) compared CBTp with supportive therapy
and found CBTp to beneﬁcially impact general psychotic symptoms
and supportive therapy to have greater speciﬁc impact on auditorythe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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of group PBCT for distressing voices. Following an earlier uncontrolled
study (Dannahy et al., 2011) the primary outcome was a measure of
general distress (CORE-OM). We also included outcomes more proxi-
mal to the targets of the PBCT therapy including voice distress, voice
control, and depression; as well as a recovery-related measure of posi-
tive interpersonal behaviour and purpose. The primary hypothesis
was that group PBCT plus treatment-as-usual (TAU), in comparison to
TAU-only, would lead to reduced distress and disturbance in people dis-
tressed by hearing voices with a diagnosis of schizophrenia or
schizoaffective disorder. A secondary hypothesis was that these effects
would be maintained six months post therapy.
2. Method
2.1. Design
This was a single blind, pragmatic randomised controlled trial (reg-
istration number ISRCTN74054823) comparing group PBCT plus TAU
(hereafter referred to as PBCT) with TAU alone (hereafter referred to
as TAU). Allocation was 1:1. Eligible participants were recruited from
two UK mental health services in Sussex and Hampshire. Recruitment
began in January 2012 and was completed in September 2013 (recruit-
ment delays required a 6month extension). Follow-up assessments ran
fromMarch 2013 to July 2014. Assessment occurred pre-randomisation,
four months post-randomisation (post-treatment) and ten months
post-randomisation (follow-up). The Brighton and Sussex Research
Ethics Committee (number 11/L0/1330) gave ethical approval.
The planned sample size of 60 participants per treatment arm was
based on yielding 80% power for detecting an effect size of d = 0.56
(Chadwick et al., 2009) with a Student's t-test, two-sided 5% alpha and
an attrition rate of 18%.
2.2. Recruitment process
Inclusion criteria were: hearing distressing voices for the preceding
year; ICD 10 (World Health Organisation, 1992: research criteria) diag-
nosis of schizophrenia or schizo−affective disorder; aged 18 years and
older. Exclusion criteria were: known organic illness; primary diagnosis
of substance misuse. Eligible participants identiﬁed by Consultant Psy-
chiatrists and Mental Health Practitioners were given information
sheets and, if interested, were asked for verbal permission to be
contacted by a study research assistant. Research assistants provided
further information, obtained written informed consent, and adminis-
tered baselinemeasures in line with the assessment protocol (the pres-
ent article presents data on main outcomes only).
2.3. Randomisation and blinding
Stratiﬁed block randomisation was completed by the Clinical Trials
Unit at King's College London. When 12–18 participants had been
consented and assessed within a centre, recruitment was closed and
participants were randomised to receive PBCT or TAU. The Trials Unit
then emailed allocation details to the centre TrialManager and research
assistant, who notiﬁed participants of their allocation. All post-
randomisation assessments were completed by research assistants
from a different geographical centre who were blind to participant allo-
cation.When breaks in blindingwere reported, assessments were com-
pleted by another research assistant who was blind to allocation.
2.4. Intervention
Group PBCTwas delivered over 12 one-and-a-half-hour sessions. All
groupswere supervised by theﬁrst author and facilitated by two clinical
psychologists experienced in either CBTp, or mindfulness, or both (ﬁve
therapists in total). The therapy manual is detailed elsewhere(Chadwick, 2006; Strauss and Hayward, 2013). Brieﬂy: All sessions
began with mindfulness practice and discussion. Mindfulness practice
in PBCT is brief (10min), with frequent guidance that includes reference
to psychotic experience, and combines focussed attention on body and
breath with open awareness. Sessions 1–3 socratically drew out partic-
ipants' voice hearing experiences (onset, impact, meaning, distress and
coping) and framed them using the ABC cognitive model. Sessions 4–6
explored personal control, socratically weakening voice omnipotence
and enhancing autonomy. Sessions 7–12 added focus on identifying
and decentring from negative schemata, and building positive schemat-
ic beliefs (including using experiential two chair work) alongside recog-
nition that the self is complex and changing. Participants were
encouraged to practice mindfulness daily at home, using a supplied
10 min recording, and each week one further homework was set relat-
ing to work on voices or self (e.g. Session 6: keeping a record of times
when I chose what to do in spite of the voices).
Therapy adherence was assessed by participants completing check-
lists indicating adherence to key protocol elements for that session
(e.g. Session 3: (i) We did a mindfulness practice, (ii) We talked about
what we noticed during the mindfulness practice, (iii) we talked
about voices using an ABC table, (iv) we were asked about what we
had learned from today's sessions). Ratings were administered by re-
search assistants at 16 randomly selected sessions, covering both sites,
and after the therapists had left. 65/67 participant ratings indicated
full adherence; at two separate sessions a participant rated one of the
four protocol elements as missing. It was not possible to record group
therapy sessions due to participant concerns.
All participants received TAU, comprising: 2–3 monthly outpatient
appointments with their psychiatrist, antipsychotic medication, and
contact with care team members every two weeks, all of which were
documented in accordance with the study protocol.
2.5. Measures
2.5.1. Primary outcome. Clinical outcomes in routine evaluation-outcome
measure (CORE-OM; Evans et al., 2000)
A 34-item self-report measure of psychological distress with ade-
quate reliability (α 0.75–0.95) developed to evaluate outcome in psy-
chological therapy (Evans et al., 2000). CORE-OM includes subscales of
well-being, problems, functioning and risk. Item scores range from 0
to 4 (higher scores indicate more distress).
2.5.2. PSYRATS: Auditory Hallucinations Scale (AHRS; Haddock et al., 1999)
A clinician rated 11-item scale assessing the severity of different di-
mensions of the voice-hearing experience (Haddock et al., 1999) includ-
ing frequency, duration, loudness, distress intensity and control. Each
item is rated 0 to 4 (higher scores indicate more difﬁculty). The authors
report good psychometric properties and inter-rater reliability (0.78–
1.00).
2.5.3. Hospital Anxiety and Depression Scale (HADS; Zigmond and Snaith,
1983)
A 14-item self-report measure of anxiety (7 items) and depression
(7 items). Items are scored 0–3, with higher scores indicating greater
distress. The HADS has well established psychometric properties
(Zigmond and Snaith, 1983) and reliability (α 0.83 for anxiety and
0.82 for depression; Bjelland et al., 2002).
2.5.4. Choice of outcome in CBT for psychoses (CHOICE; Greenwood et al.,
2010)
A 24-item self-report questionnaire developed with patients to as-
sess goals for CBTp related to recovery (e.g. self-conﬁdence, positive
ways of relating to people, and a positive purpose and direction in
life) that is reliable (α 0.83 for Severity and 0.88 for Satisfaction) and
valid (Greenwood et al., 2010). Each item is rated on a 10-point scale
170 P. Chadwick et al. / Schizophrenia Research 175 (2016) 168–173for (1) severity and (2) satisfaction (higher scores indicate better
functioning).
2.6. Statistical analyses
All outcomes (excluding distress intensity and control) were evalu-
ated using Analysis of Covariance (ANCOVA) at post treatment
(4 months) and at follow-up (10 months) separately using the
intention-to-treat (ITT) principle where all participants were analysed
as per their randomisation allocation. Corresponding baseline scores
were used as covariates in the ANCOVA and centre (Sussex or Hamp-
shire) and treatment group (PBCT + TAU or TAU only) were treated
as ﬁxed factors. All analyses were carried out in STATA (version 13);
treatment effects were estimated using regress. Due to the ordinal na-
ture of the distress intensity and control outcomes, non-parametric
methodology was used to conduct a between-group comparison of
the change in scores from baseline to the post treatment and follow-
up, separately. The change scores for each group were compared using
a Mann-Whitney test for unpaired groups (using STATA ranksum) and
then the Cohen's d standardised treatment effect size was calculated
from the Z-scores (Lenhard and Lenhard, 2015).
Missing follow-up data is commonly experienced in longitudinal tri-
als and it is often assumed that the data are missing at random (MAR).
We looked at the predictability of missingness from other non-missing
variables and theMAR assumptionwas deemed appropriate. To address
the impact of drop-outs, adjustment rates were calculated using inverse
probability weights that could be used in the regressionmodels to com-
pensate for the missing values (Little and Rubin, 1987). For each indi-
vidual, the probability of providing follow-up data at 4 and 10 monthsFig. 1. Flow of participantseparately was estimated using treatment compliance (attended at
least 8 sessions), centre, treatment group and the baseline outcome
value as predictors in an unweighted logistic regression (using STATA
logit). The adjustment weight was calculated as the reciprocal of this
probability which was then entered in the regression model used in
the main analyses. The unstandardised treatment effect was taken di-
rectly from the coefﬁcient for the treatment group. The standardised ef-
fect (Cohen's d) was calculated from the treatment group coefﬁcient
divided by the corresponding outcome pooled SD at baseline. Estimated
unadjusted (complete case analysis) and adjusted (for drop-out) treat-
ment effects are reported with their standard error, 95% conﬁdence in-
terval, signiﬁcance levels and Cohen's d. No adjustments were made for
the distress intensity and control outcomes. An exploratory per-
protocol analysis was also carried out where the outcomes of partici-
pants who were treatment compliant (i.e. attended 8 or more therapy
sessions) were compared with the TAU group.
3. Results
The CONSORT diagram shows the trial proﬁle (see Fig. 1). Sixty-
three participants were recruited in the Sussex centre and forty-ﬁve
participants in Hampshire. Three PBCT groups were run in Hampshire
and four in Sussex.
39 participants (72%) randomised to PBCT attended at least 8 ses-
sions (‘completers’). Eight participants randomised to PBCT attended
no sessions (three dropped out of the study, and ﬁve completed at
least one post-randomisation assessment); of those who attended at
least one session, 85% completed therapy. Study retention was 93/108
(86%) at 4-months and 82/108 (76%) at 10-months assessments (thes through the study.
Table 1
Socioeconomic proﬁles and outcome measures at baseline.
PBCT + TAU
(n= 54)
TAU (n= 54)
Gender
Male 27 (50) 26 (48)
Female 27 (50) 27 (50)
Age median years (range) 42 (18–65) 42 (19–59)
Ethnicity
White British 49 (91) 49 (91)
Black & minority ethnicity 5 (9) 5 (9)
Site
Sussex 31 (58) 32 (59)
Hampshire 23 (43) 22 (41)
Employment status
Employed 9 (17) 7 (13)
Unemployed 39 (72) 43 (80)
Other 6 (11) 4 (8)
Education Level (ISCE)
Primary 9 (17) 11 (20)
Lower secondary 23 (43) 18 (33)
Upper secondary 11 (20) 5 (9)
Post-secondary non-tertiary education 5 (9) 9 (17)
Short-cycle tertiary education 1 (2) 5 (9)
Bachelor or equivalent 5 (9) 6 (11)
Age of hearing voices median years (range) 22 (7–50) 20 (5–55)
CORE-OM mean 1.81 (0.70) 1.91 (0.66)
HADS depression total 9.70 (4.91) 10.26 (4.45)
HADS anxiety total 13.26 (3.65) 13.57 (3.69)
CHOICE severity mean 4.41 (1.92) 4.03 (1.62)
CHOICE satisfaction mean 3.77 (2.20) 3.48 (1.98)
PSYRATS total 30.35 (5.55) 30.20 (7.11)
PSYRATS distress intensity score* 3 (0–4) 3 (0–4)
PSYRATS control score* 4 (0–4) 3 (0–4)
Values are numbers (percentages) or Mean (SD), unless otherwise indicated; * indicates
variables summarised using median (range) because the scale item is ordinal and the
data distribution is skewed. ISCE = 2011 International Standard Classiﬁcation of Educa-
tion, CORE-OM = clinical outcomes in routine evaluation Outcome Measure, HADS =
Hospital Anxiety & Depression Scale, PSYRATS = psychotic symptom rating scales,
CHOICE = self-report assessment of recovery.
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Steering Committee and deemed highly unlikely to be related to the
study). Data were missing from 14% of participants post treatment
and 24% of participants at follow-up.3.1. Sample characteristics
In the study sample, 53 (50%)weremale; themedian age of the par-
ticipants was 42 years (range 18–65); the median onset age of hearing
voices was 21 years (range 5–55); 98 (91%) were White British; 82
(76%) were unemployed, 16 (15%) were employed and 10 (9%) hadTable 2
Primary and secondary outcomes at 4 months and 10 months.
4 months
PBCT + TAU (n= 54) TAU (n=
CORE-OM mean 1.58 (0.77); n= 48 1.71 (0.55
HADS depression total 7.96 (5.20); n= 48 9.71 (3.80
HADS anxiety total 11.73 (4.32); n= 48 12.44 (3.6
CHOICE severity mean 5.00 (2.01); n= 48 4.39 (1.48
CHOICE satisfaction mean 4.62 (2.28); n= 48 3.83 (1.85
PSYRATS total 26.92 (7.81); n= 48 27.43 (8.3
PSYRATS distress intensity* 3 (0–4); n= 48 3 (0–4); n
PSYRATS control* 3 (0–4); n= 48 4 (1–4); n
Values are mean (SD) or *indicates variables summarised using median (range) because the sc
numbers (n) are provided to indicate samples with complete data. CORE-OM = clinical outc
psychotic symptom rating scales; CHOICE = self-report assessment of recovery.another status e.g. retired. In terms of highest level of education re-
ceived, 20 (19%) had primary education, 41 (38%) had lower secondary
education, 16 (15%) had upper secondary education, 14 (13%) had post-
secondary non-tertiary, 6 (6%) had short-cycle tertiary education and
11 (10%) had bachelor degrees or equivalent. In terms of clinical diagno-
sis, all participants had a diagnosis of Schizophrenia or Schizoaffective
disorder. Baseline characteristics between the two study arms were
similar (Table 1).
3.2. Outcomes
Table 2 displays the summary statistics for the outcome measures.
The CORE-OM post-treatment mean score, the primary endpoint,
was lower in the PBCT condition compared with the TAU condition.
This is shown in the estimates of treatment effects from the cross-
sectional analyses (Table 3). The estimated between-group effect
size (unstandardized) and corresponding 95% Conﬁdence Interval (CI)
post treatment was −0.14 (95% CI −0.337 to 0.007; p = 0.188)
which equates to a standardised effect size (Cohen's d) of−0.20. The
corresponding adjusted between-group effect size was−0.157 (95%
CI−0.35 to 0.04) and adjusted Cohen's d, d*=−0.23. The Bayes factor
for a sample difference between PBCT and TAU (of 0.135, SE = 0.102)
was 0.71 which implies that the data are not sensitive enough to con-
clude whether or not there is a difference between the two groups
(Dienes, 2008).
The estimated unadjusted and adjusted treatment effects for distress
and disturbance at follow-up (CORE-OM) and speciﬁc measures of dis-
tress (PSYRATS distress intensity and HADS depression and anxiety)
and disturbance (PSYRATS control, CHOICE Severity and CHOICE Satis-
faction) shown in Tables 3 & 4 demonstrate favourable changes in fa-
vour of PBCT, although not all were statistically signiﬁcant. At post-
treatment there were signiﬁcant between-group effects on measures
of distress (HADS depression and PSYRATS distress intensity) and dis-
turbance (PSYRATS control, CHOICE Severity and CHOICE Satisfaction),
but signiﬁcant effects were maintained at follow-up only for HADS de-
pression. In addition, the statistical signiﬁcance for the post-treatment
effect of CHOICE Severity became non-signiﬁcant when it was adjusted.
The PBCT intervention did not have demonstrable effects on the CORE-
OM at follow-up or on HADS Anxiety at post-treatment or follow up.
Exploratory per-protocol analysis ﬁndings were in line with, and did
not alter, the ITT analysis ﬁndings.
4. Discussion
The study examined effectiveness of group PBCT on distress and
disturbance in people distressed by hearing voices with an ICD-10 diag-
nosis of schizophrenia or schizoaffective disorder. Between-group effect
sizes on general psychological distress (CORE-OM) at post-intervention
and follow-up were small (in favour of PBCT) and non-signiﬁcant. In-
tensity of voice distress was improved post-treatment - the ﬁrst RCT10 months
54) PBCT + TAU (n= 54) TAU (n= 54)
); n= 45 1.57 (0.72); n= 43 1.68 (0.62); n= 39
); n= 45 7.62 (4.95); n= 42 9.21 (3.71); n= 38
2); n= 45 11.71 (4.44); n= 42 12.50 (3.56); n= 38
); n= 44 5.17 (1.77); n= 42 4.65 (1.56); n= 38
); n= 44 4.56 (1.98); n= 42 4.22 (2.18); n= 38
5); n= 44 28 (7.62); n= 42 24.94 (10.35); n= 38
= 44 2.5 (0–4); n= 42 2.5 (0–4); n= 36
= 43 3 (0–4); n= 41 3 (0–4); n= 36
ale item is ordinal and the data distribution is skewed. Some scales have missing data and
omes in routine evaluation; HADS = Hospital Anxiety & Depression Scale; PSYRATS =
Table 3
Estimates of unadjusted and adjusted treatment effect at each time point.
Unadjusted Adjusted
Estimate (SE) 95% CI P value Standardised treatment effecta Estimate (SE) 95% CI P value Standardised treatment effect
CORE-OM mean
4 months −0.135 (0.102) −0.337 to 0.067 0.188 −0.198 −0.157 (0.099) −0.353 to 0.039 0.114 −0.231
10 months −0.108 (0.134) −0.373 to 0.158 0.423 −0.158 −0.154 (0.131) −0.416 to 0.107 0.243 −0.227
HADS anxiety total
4 months −0.648 (0.705) −2.049 to 0.754 0.361 −0.177 −0.649 (0.674) −1.989 to 0.69 0.338 −0.178
10 months −0.865 (0.874) −2.605 to 0.875 0.325 −0.236 −0.726 (0.809) −2.339 to 0.886 0.372 −0.199
HADS depression total
4 months −1.743 (0.712) −3.157 to−0.328 0.016 −0.373 −1.67 (0.719) −3.1 to−0.241 0.023 −0.358
10 months −1.489 (0.74) −2.962 to−0.016 0.048 −0.319 −1.456 (0.685) −2.821 to−0.092 0.037 −0.312
Choice severity mean
4 months 0.653 (0.298) 0.06 to 1.245 0.031 0.367 0.581 (0.3) −0.015 to 1.177 0.056 0.327
10 months 0.401 (0.318) −0.233 to 1.035 0.212 0.225 0.35 (0.319) −0.286 to 0.986 0.277 0.197
Choice satisfaction mean
4 months 0.881 (0.383) 0.119 to 1.643 0.024 0.422 0.879 (0.372) 0.141 to 1.618 0.020 0.421
10 months 0.363 (0.433) −0.499 to 1.226 0.404 0.174 0.387 (0.416) −0.442 to 1.216 0.356 0.185
PSYRATS total
4 months −1.198 (1.509) −4.196 to 1.801 0.430 −0.189 −1.273 (1.488) −4.23 to 1.685 0.395 −0.201
10 months 2.331 (2.007) −1.667 to 6.329 0.249 0.367 2.449 (2.082) −1.696 to 6.595 0.243 0.386
CORE-OM= clinical outcomes in routine evaluation; HADS = Hospital Anxiety & Depression Scale; PSYRATS = psychotic symptom rating scales; CHOICE = self-report assessment of
recovery.
a Treatment effect divided by the baseline variance.
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provement in depression: CBTp trials focussing on voices have typically
not found effects on depression (Birchwood et al., 2014; Penn et al.,
2009; Trower et al., 2004). The study also found post-intervention re-
duction in feeling controlled by voices – easing voice omnipotence is a
vital early goal in psychosocial interventions for distressing voices
(Chadwick et al., 2000). Furthermore, there was a signiﬁcant effect on
CHOICE, a patient generated measure of behavioural disturbance and
positive action.
The present study has limitations. First, the study did notmeet its re-
cruitment target (there was no suggestion this was due to the speciﬁc
therapy) andwas unable to provide a deﬁnitive test on the primary out-
comemeasure (CORE-OM); recruitment delays, particularly in one site,
may have contributed to 8 participants randomised to PBCT not attend-
ing a single session. It is encouraging that 85% of participants who
attended at least one session went on to complete therapy. Relatedly,
whilst recognition is growing that primary outcome in CBTp should re-
late to distress and disturbance, there is no agreed outcomemeasure for
assessing this with voices (see Thomas et al., 2014). The CORE-OMwas
developed to assess global psychological distress in broad psychothera-
py research andmay not be the best outcomemeasure in CBTp research.
Future PBCT research should prioritise measures that assess change in
variables directly targeted by the intervention (e.g. voice distress, de-
pression, behaviour change). Second, the lack of an active control
group, while appropriate for an initial assessment of PBCT effectiveness,
leaves open the possibility of either placebo effects or effects due toTable 4
Estimate of standardised treatment effect at each time point: Mann-Whitney test results.
Number of
observations
Z p value Standardised treatment
effect Cohen's d
PSYRATS distress intensity
4 months 91 −2.315 0.021 −0.500
10 months 77 −0.758 0.449 −0.173
PSYRATS control
4 months 89 −2.003 0.045 −0.435
10 months 76 −1.909 0.056 −0.449
Note: Treatment effects estimated using the Lenhard and Lenhard (2015) effect size
conversion calculator.nonspeciﬁc group factors (our research indicates the importance of uni-
versality in mindfulness groups for psychosis: Chadwick et al., 2009,
p. 410). Third, the studydid not assess completion of homework. Finally,
whilst the effect on depression was maintained at 6-month follow-up,
other positive effects were not. PBCT targets change in a number of do-
mains – delusional beliefs; relationship with positive psychotic symp-
toms; mindfulness; positive behaviour change; and a more balanced,
ﬂexible and accepting self-concept. Future research should examine a
longer intervention phase to consolidate the important post-treatment
gains seen - supplementing face-to-face sessions with e-Health and
m-Health mindfulness platforms might consolidate gains without re-
ducing accessibility. Future research might also assess use of antipsy-
chotic medication and mental health services, including admission to
hospital; and whilst protocol adherence was assessed in the present
study, future research could also use independent raters to assess com-
petence of delivery.
In sum, the ﬁndings of post-group effects on depression, voice
distress, voice controllability and recovery provide amandate for future
research. Overall when delivered over 12 weeks, group PBCT for
distressing voices shows promise as an intervention to reduce the dis-
tress and disturbance associated with voice hearing experiences in the
context of psychosis.
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